ASIC3 and irritable bowel syndrome: From this perspective, selective blockade of ASICs, in particular ASIC3, may provide interesting therapeutic tools to treat visceral hypersensitivity and pain associated with functional and inflammatory chronic gut diseases, such as IBS and IBD [239].